메뉴 건너뛰기




Volumn 10, Issue SUPPL. 1, 2000, Pages 53-56

High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer

Author keywords

Dose intensity; High dose chemotherapy; Ovarian cancer; Peripheral blood stem cell transplantation

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; MELPHALAN; PACLITAXEL; PLATINUM;

EID: 0034003376     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.99512.x     Document Type: Article
Times cited : (8)

References (14)
  • 1
    • 0026055728 scopus 로고
    • Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials
    • Advanced Ovarian Cancer Trialists Group. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Br Med Journal 1991; 303: 884-93.
    • (1991) Br Med Journal , vol.303 , pp. 884-893
  • 2
    • 0026009503 scopus 로고
    • Long Term Survival in Ovarian Cancer: Mature Data from the Netherlands Joint Study Group for Ovarian Cancer
    • Neijt JP, ten Bokkel Huinink WW, van der Burg MEL et al. Long Term Survival in Ovarian Cancer: Mature Data from The Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer 1991; 27: 1367-72.
    • (1991) Eur J Cancer , vol.27 , pp. 1367-1372
    • Neijt, J.P.1    Ten Bokkel Huinink, W.W.2    Van Der Burg, M.E.L.3
  • 3
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    • McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
    • (1996) N Engl J Med , vol.334 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3
  • 4
    • 0000264166 scopus 로고    scopus 로고
    • Updated analysis shows a highly significant improvement in overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer: Mature results of the EORTC-GCCG, NOCOVA,NCIC and Scottish Intergroup trial
    • abstract
    • Stuart G, Bertelsen K, Mangioni C et al. Updated analysis shows a highly significant improvement in overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer: Mature results of the EORTC-GCCG, NOCOVA,NCIC and Scottish Intergroup trial. Proc Am Soc Clin Oncol 1998; 17: 361a (abstract).
    • (1998) Proc Am Soc Clin Oncol , vol.17
    • Stuart, G.1    Bertelsen, K.2    Mangioni, C.3
  • 6
    • 0030920691 scopus 로고    scopus 로고
    • How many more nails to seal the coffin of dose intensity?
    • McGuire W. How many more nails to seal the coffin of dose intensity? Ann Oncol 1997; 8: 311-3.
    • (1997) Ann Oncol , vol.8 , pp. 311-313
    • McGuire, W.1
  • 7
    • 0000599076 scopus 로고
    • High dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer in Cancer of the Ovary
    • Hoskins WJ, Markman M, eds. New York: Raven Press
    • Shpall E, Stemmer S, Bearman S et al. High dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer in Cancer of the Ovary. In: Hoskins WJ, Markman M, eds. Cancer of the Ovary. New York: Raven Press, 1993: 327-38.
    • (1993) Cancer of the Ovary , pp. 327-338
    • Shpall, E.1    Stemmer, S.2    Bearman, S.3
  • 8
    • 0030901014 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: A multivariate analysis of survival for 100 consecutively treated patients
    • Stiff PJ, Bayer R, Kerger C et al. High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. J Clin Oncol 1997; 15: 1309-17.
    • (1997) J Clin Oncol , vol.15 , pp. 1309-1317
    • Stiff, P.J.1    Bayer, R.2    Kerger, C.3
  • 9
    • 17344382260 scopus 로고    scopus 로고
    • High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results
    • Legros M, Dauplat J, Fleury J et al. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol 1997; 15: 1302-8.
    • (1997) J Clin Oncol , vol.15 , pp. 1302-1308
    • Legros, M.1    Dauplat, J.2    Fleury, J.3
  • 10
    • 0002768303 scopus 로고    scopus 로고
    • High Dose Chemotherapy in Ovarian Cancer: An Analysis of the Experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 Years
    • abstract
    • Ledermann JA, Herd R, Maraninchi D et al. High Dose Chemotherapy in Ovarian Cancer: an Analysis of the Experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 Years. Proc Am Soc Clin Oncol 1999; 18: 360a (abstract).
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Ledermann, J.A.1    Herd, R.2    Maraninchi, D.3
  • 11
    • 0029116891 scopus 로고
    • High-dose chemotherapy with haematopoetic rescue as primary treatment for metastatic breast cancer: A randomzed trial
    • Bezwoda WR, Seymour L, Dansey RD. High-dose chemotherapy with haematopoetic rescue as primary treatment for metastatic breast cancer: a randomzed trial. J Clin Oncol 1995; 13: 2483-9.
    • (1995) J Clin Oncol , vol.13 , pp. 2483-2489
    • Bezwoda, W.R.1    Seymour, L.2    Dansey, R.D.3
  • 12
    • 0003344884 scopus 로고    scopus 로고
    • Randomised, controlled trial of high dose chemotherapy (HD-CNVP) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer
    • abstract
    • Bezwoda W. Randomised, controlled trial of high dose chemotherapy (HD-CNVP) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer. Proc Am Soc Clin Oncol 1999; 18: 2a (abstract).
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Bezwoda, W.1
  • 13
    • 0029053113 scopus 로고
    • Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/ cyclophosphamide courses
    • Fennelly D, Schneider J, Spriggs D et al. Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/ cyclophosphamide courses. J Clin Oncol 1995; 13: 1160-6.
    • (1995) J Clin Oncol , vol.13 , pp. 1160-1166
    • Fennelly, D.1    Schneider, J.2    Spriggs, D.3
  • 14
    • 0032945999 scopus 로고    scopus 로고
    • Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: A phase I/II study in advanced ovarian cancer
    • Wandt H, Birkmann J, Denzel T et al. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Bone Marrow Transplant 1999; 23: 763-70.
    • (1999) Bone Marrow Transplant , vol.23 , pp. 763-770
    • Wandt, H.1    Birkmann, J.2    Denzel, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.